AX-08
A dual-agonist compound targeting GLP-1 and GIP receptor pathways simultaneously, with published preclinical data on insulin sensitization, hepatic lipid oxidation, and appetite regulation via hypothalamic signaling. Clinical experts regard multi-receptor agonism as the frontier of metabolic research due to its non-linear efficacy profile.
purity
≥99%
quantity
5mg
form
Lyophilized powder
storage
Store at -20°C
FOR RESEARCH AND LABORATORY USE ONLY. Not for human consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.